The GenusPlus share price has doubled in 12 months. We explore what’s driving the growth and why brokers are still bullish.

Monash IVF shares have had a rollercoaster journey this year following controversial incidents. Does Macquarie still rate them a buy?

Let's see what makes these ASX dividend shares potential no-brainer buys right now for income investors with $1,000 to put to ...

This ASX share is up 115% in a year, driven by strong earnings, recurring revenue, and upgraded guidance for FY25.

The DroneShield share price was a standout performer in July. Here's why its shares rocketed higher during the ...

These ASX ETFs could be worth a look if you have $10,000 to invest in the share market this month. Let's see what they ...

For those investors sailing the high seas for battered stocks that are undervalued, these ASX 200 shares fell more than 50% ...

These two ASX value stocks offer investors great value, in my opinion. I think they’re two underrated S&P/ASX 300 Index (ASX: ...

The US Magnificent Seven stocks have lost significance, says Betashares senior investment strategist, Cameron Gleeson. Here's ...

Macquarie combines these six variables into an econometric model to explain ASX 200 absolute bank performance since 2004.

Here's what you need to know about them: Catalyst Metals could be an ASX mining stock to buy according to the team at Morgans ...

The share price of this ASX 200 retailer has surged over the past 12 months. Do analysts think there could be room for more?